7XB-26256-95134
3 vaccinations
3 coded responses
18 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 770 / TX
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
5FB-14965-71803
Child or adolescent in my care · Male · 2022-06-27
Timeline
-
2021-03-15
Dose 1 — Pfizer-BioNTech
-
2021-03-25
Registered in v-safe
- 2021-03-25
- 2021-03-29
-
2021-04-05
Dose 2 — Pfizer-BioNTech
-
2021-04-05
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
-
2021-05-12
Survey response — day 35, dose 2MedDRA: Chills, Headache, Nausea, Pyrexia — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: A headache, nausea, fever, and chills. It has since resolved.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-17
- 2021-07-05
-
2021-10-04
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: A severe cold, but I have tested negative for COVID.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-22
Dose 3 — Pfizer-BioNTech
-
2022-04-05
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Got COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-04-05
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-07
- 2022-10-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Pfizer-BioNTech | |
| 2 | 2021-04-05 | Pfizer-BioNTech | |
| 3 | 2021-10-22 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-05 | Unsuccessful |
Free text
Release 8 — day 35, dose 2
Symptoms: A headache, nausea, fever, and chills. It has since resolved.
Release 10 — 6 months, dose 2
Symptoms: A severe cold, but I have tested negative for COVID.
Release 11 — 12 months, dose 2
Symptoms: Got COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release